5Cheng W S, Wei S J, Liu J M et al. Tumor invasiveness and liver metast6asis of colon cancer cells correlated with cyclooxygenase-2 ( COX- 2) expression and inhibited by a Cox-2 selective inhibitor, etodolac[J]. Int Jcancer, 2001 ; 91 (6) : 894-899.
6Uefuji K, Ichikura T, Mochizuki H. Expression of cyclooxygenase-2 in human gastric adenomas and adenocarcinomas[ J ]. J Surg Onocol, 2001;76 (1) :26-30.
7Rohayem J, Diestelkoetter P, Weigle Bet al. Antibody response to the tumor associated inhibitor of apoptosis protein survivin in cancer patients [J]. Cancer Res,2000;60(7) : 1815-1817.
8Kato J, Kuwabara Y, Mitani M et al. Expression of Survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy[J]. Int J Cancer,2001 ;95:92-95.
9Rahman M A, Dhar DK, Yamaguchi E et al. Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver:possible involvement of COX-2 in the angiogenesis of hepatitis C viruspositive cases[J]. Clin Cancer Res,2001 ;7(5) : 1325-1332.
10Koga H, Sakisaka S, Ohishi Met al. Expression of cyclooxygenase-2 in human hepatocelltrlar carcinoma: relevance to tumor differentiation [ J ]. Hepatology, 1999;29(3) :688-696.
